Nutrition priorities in the GLP-1 era Protein for satiety and lean mass preservation One of the most significant concerns for individuals using GLP-1 medications is the potential for excessive lean body mass loss
Draft scope post-referral: retatrutide technology appraisal GID-TA11525
In one retrospective study involving 313 patients, the left colon was most frequently involved (32.6%), followed by the right colon (25.2%), distal colon (24.6%), transverse colon (10.2%), and entire colon (7.3%) [24]
Burn Fat When you exercise, your body has the ability to burn fat and convert it into energy
In terms of public insurance , some provincial drug programs may provide coverage for Wegovy, typically requiring patients to meet certain medical criteria related to obesity
Clean the Injection Site : Using an alcohol swab, thoroughly clean the injection site on the stomach, thigh, or upper arm to minimize the risk of infection